Total Payments
$65,939
2024 Payments
$27,226
Companies
10
Transactions
101
Medicare Patients
662
Medicare Billing
$54,109
Payment Breakdown by Category
Consulting$48,075 (72.9%)
Other$9,541 (14.5%)
Travel$4,665 (7.1%)
Food & Beverage$3,603 (5.5%)
Education$55.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $48,075 | 25 | 72.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,016 | 6 | 13.7% |
| Travel and Lodging | $4,665 | 24 | 7.1% |
| Food and Beverage | $3,603 | 44 | 5.5% |
| Honoraria | $525.00 | 1 | 0.8% |
| Education | $55.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Glaukos Corporation | $51,692 | 53 | $0 (2024) |
| Oyster Point Pharma, Inc. | $13,366 | 37 | $0 (2024) |
| Tarsus Pharmaceuticals, Inc. | $287.96 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $132.14 | 2 | $0 (2019) |
| Johnson & Johnson Surgical Vision, Inc. | $124.17 | 1 | $0 (2018) |
| Shire North American Group Inc | $119.39 | 1 | $0 (2017) |
| Johnson & Johnson Vision Care, Inc. | $113.83 | 1 | $0 (2019) |
| Bausch & Lomb Americas Inc. | $55.00 | 1 | $0 (2024) |
| Allergan, Inc. | $35.54 | 2 | $0 (2020) |
| Alcon Vision LLC | $12.83 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $27,226 | 32 | Glaukos Corporation ($23,924) |
| 2023 | $28,263 | 45 | Glaukos Corporation ($18,221) |
| 2022 | $9,059 | 11 | GLAUKOS CORPORATION ($8,693) |
| 2021 | $793.43 | 4 | Glaukos Corporation ($793.43) |
| 2020 | $79.93 | 2 | Glaukos Corporation ($59.50) |
| 2019 | $258.80 | 4 | Novartis Pharmaceuticals Corporation ($132.14) |
| 2018 | $124.17 | 1 | Johnson & Johnson Surgical Vision, Inc. ($124.17) |
| 2017 | $134.50 | 2 | Shire North American Group Inc ($119.39) |
All Payment Transactions
101 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | Glaukos Corporation | CE-marked KXLA system (Device) | Food and Beverage | Cash or cash equivalent | $48.96 | General |
| Category: Corneal Health | ||||||
| 11/20/2024 | Glaukos Corporation | CE-marked KXLA system (Device) | Consulting Fee | Cash or cash equivalent | $2,437.50 | General |
| Category: Corneal Health | ||||||
| 11/08/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug), Ryzumvi | Food and Beverage | In-kind items and services | $31.66 | General |
| Category: Dry eyes | ||||||
| 11/07/2024 | Tarsus Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $139.24 | General |
| 11/05/2024 | Tarsus Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $148.72 | General |
| 09/11/2024 | Glaukos Corporation | CE-marked KXLA system (Device) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Corneal Health | ||||||
| 09/11/2024 | Glaukos Corporation | CE-marked KXLA system (Device) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Corneal Health | ||||||
| 09/11/2024 | Glaukos Corporation | CE-marked KXLA system (Device) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Corneal Health | ||||||
| 09/11/2024 | Glaukos Corporation | CE-marked KXLA system (Device) | Travel and Lodging | Cash or cash equivalent | $726.14 | General |
| Category: Corneal Health | ||||||
| 09/11/2024 | Glaukos Corporation | CE-marked KXLA system (Device) | Travel and Lodging | Cash or cash equivalent | $631.84 | General |
| Category: Corneal Health | ||||||
| 07/10/2024 | Glaukos Corporation | CE-marked KXLA system (Device) | Food and Beverage | Cash or cash equivalent | $28.97 | General |
| Category: Corneal Health | ||||||
| 07/03/2024 | Glaukos Corporation | CE-marked KXLA system (Device) | Consulting Fee | Cash or cash equivalent | $5,360.00 | General |
| Category: Corneal Health | ||||||
| 07/03/2024 | Glaukos Corporation | CE-marked KXLA system (Device) | Consulting Fee | Cash or cash equivalent | $4,046.14 | General |
| Category: Corneal Health | ||||||
| 07/03/2024 | Glaukos Corporation | CE-marked KXLA system (Device) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: Corneal Health | ||||||
| 07/03/2024 | Glaukos Corporation | CE-marked KXLA system (Device) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Corneal Health | ||||||
| 07/03/2024 | Glaukos Corporation | CE-marked KXLA system (Device) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Corneal Health | ||||||
| 07/03/2024 | Glaukos Corporation | CE-marked KXLA system (Device) | Travel and Lodging | Cash or cash equivalent | $61.64 | General |
| Category: Corneal Health | ||||||
| 07/03/2024 | Glaukos Corporation | CE-marked KXLA system (Device) | Travel and Lodging | Cash or cash equivalent | $53.60 | General |
| Category: Corneal Health | ||||||
| 06/21/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Education | In-kind items and services | $55.00 | General |
| Category: Ophthalmology | ||||||
| 06/19/2024 | Glaukos Corporation | CE-marked KXLA system (Device) | Consulting Fee | Cash or cash equivalent | $1,750.00 | General |
| Category: Corneal Health | ||||||
| 05/10/2024 | Glaukos Corporation | Photrexa (Drug) | Food and Beverage | Cash or cash equivalent | $104.41 | General |
| Category: Corneal Health | ||||||
| 03/13/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,700.00 | General |
| Category: Dry eyes | ||||||
| 03/13/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Dry eyes | ||||||
| 03/13/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Travel and Lodging | Cash or cash equivalent | $17.69 | General |
| Category: Dry eyes | ||||||
| 03/13/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Travel and Lodging | Cash or cash equivalent | $7.00 | General |
| Category: Dry eyes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 214 | 304 | $139,925 | $20,100 |
| 2022 | 5 | 180 | 255 | $87,525 | $16,279 |
| 2021 | 5 | 176 | 214 | $62,000 | $12,595 |
| 2020 | 3 | 92 | 120 | $30,300 | $5,134 |
Total Patients
662
Total Services
893
Medicare Billing
$54,109
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 79 | 111 | $44,400 | $8,317 | 18.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 83 | 141 | $38,775 | $6,884 | 17.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 21 | 21 | $15,750 | $3,171 | 20.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 15 | 15 | $9,000 | $1,175 | 13.1% |
| 92313 | Contact lens services for lens covering entire cornea | Facility | 2023 | 16 | 16 | $32,000 | $553.35 | 1.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 73 | 109 | $43,600 | $8,375 | 19.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 66 | 105 | $28,875 | $5,297 | 18.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 16 | 16 | $9,600 | $1,554 | 16.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 12 | 12 | $4,800 | $852.96 | 17.8% |
| 92025 | Ct scan of cornea | Facility | 2022 | 13 | 13 | $650.00 | $200.24 | 30.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 51 | 70 | $19,250 | $3,976 | 20.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 39 | 47 | $18,800 | $3,858 | 20.5% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Facility | 2021 | 54 | 65 | $13,000 | $2,572 | 19.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 17 | 17 | $10,200 | $1,994 | 19.5% |
| 92025 | Computerized mapping of corneal curvature | Facility | 2021 | 15 | 15 | $750.00 | $195.75 | 26.1% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Facility | 2020 | 64 | 88 | $17,600 | $3,339 | 19.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 12 | 12 | $7,200 | $1,168 | 16.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 16 | 20 | $5,500 | $626.86 | 11.4% |
About Gloria Chiu
Gloria Chiu is a Corneal and Contact Management healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2008. The National Provider Identifier (NPI) number assigned to this provider is 1174786065.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Gloria Chiu has received a total of $65,939 in payments from pharmaceutical and medical device companies, with $27,226 received in 2024. These payments were reported across 101 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($48,075).
As a Medicare-enrolled provider, Chiu has provided services to 662 Medicare beneficiaries, totaling 893 services with total Medicare billing of $54,109. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Corneal and Contact Management
- Location Los Angeles, CA
- Active Since 07/10/2008
- Last Updated 11/27/2023
- Taxonomy Code 152WC0802X
- Entity Type Individual
- NPI Number 1174786065
Products in Payments
- CE-marked KXLA system (Device) $23,820
- KXL system (not refurbished) (Device) $15,930
- TYRVAYA (Drug) $13,366
- ILINK (Device) $3,800
- KXL System (Device) $191.23
- XIIDRA (Drug) $126.70
- iDesign Advanced Wavescan Studio (Device) $124.17
- Acuvue (Device) $113.83
- Photrexa (Drug) $104.41
- iStent inject W (Device) $77.20
- ISTENT INJECT W (Device) $75.82
- Photrexa (Device) $59.50
- MIEBO (Drug) $55.00
- XEN (Device) $20.43
- DAILIES (Device) $12.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Corneal and Contact Management Doctors in Los Angeles
Dr. Gregory Kame, Od Faao, OD FAAO
Corneal and Contact Management — Payments: $18,656
Corneal and Contact Management $18,656
Dr. Karen Yeung, Od, OD
Corneal and Contact Management — Payments: $14,657
Corneal and Contact Management $14,657
Dr. Paul Super, Od, OD
Corneal and Contact Management — Payments: $4,192
Corneal and Contact Management $4,192
Dr. Shahrokh Dayyani, O.d, O.D
Corneal and Contact Management — Payments: $4,154
Corneal and Contact Management $4,154
Ms. Emily Cheng, Od, OD
Corneal and Contact Management — Payments: $4,001
Corneal and Contact Management $4,001
Jonathan Gording, O.d, O.D
Corneal and Contact Management — Payments: $3,511
Corneal and Contact Management $3,511